BAG5 and endometrial cancer: Gene set variation analysis (GSVA) revealed that BAG5+ cells were enriched in multiple oncogenic pathways, including those involved in colorectal, pancreatic, and endometrial cancers (Figure 4C), which suggests that BAG5 may converge on evolutionarily conserved oncogenic programs.